Slrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Slrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Slrx Today - Breaking & Trending Today

Salarius Pharmaceuticals (NASDAQ:SLRX) Stock Price Up 7.5%

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX – Get Free Report)’s share price rose 7.5% during trading on Wednesday . The stock traded as high as $0.54 and last traded at $0.54. Approximately 39,529 shares traded hands during mid-day trading, a decline of 58% from the average daily volume of 93,379 shares. The stock had previously closed at […] ....

Institutional Trading Of Salarius Pharmaceuticals , Salarius Pharmaceuticals Inc , Salarius Pharmaceuticals Company Profile , Salarius Pharmaceuticals Stock , Salarius Pharmaceuticals , Armistice Capital , News Ratings For Salarius Pharmaceuticals Daily , Exchange Commission , Get Free Report , Free Report , Salarius Pharmaceuticals Daily , Nasdaq Slrx ,

Short Interest in Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Declines By 26.4%

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX – Get Free Report) was the recipient of a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 20,300 shares, a decline of 26.4% from the August 31st total of 27,600 shares. Currently, 0.6% of the company’s shares are short sold. […] ....

Salarius Pharmaceuticals Company Profile , Salarius Pharmaceuticals , Renaissance Technologies , Salarius Pharmaceuticals Stock Down , Institutional Trading Of Salarius Pharmaceuticals , News Ratings For Salarius Pharmaceuticals Daily , Salarius Pharmaceuticals Inc , Exchange Commission , Get Free Report , Pharmaceuticals Stock Down , Free Report , Salarius Pharmaceuticals Daily , Nasdaq Slrx ,

Short Interest in Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Rises By 162.9%

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX – Get Free Report) was the target of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 27,600 shares, a growth of 162.9% from the August 15th total of 10,500 shares. Currently, 0.8% of the company’s shares are sold short. […] ....

Salarius Pharmaceuticals Inc , Renaissance Technologies , Salarius Pharmaceuticals , Salarius Pharmaceuticals Stock , Exchange Commission , News Ratings For Salarius Pharmaceuticals Daily , Get Free Report , Free Report , Salarius Pharmaceuticals Daily , Nasdaq Slrx ,

Salarius Pharmaceuticals (NASDAQ:SLRX) Downgraded to "Neutral" at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH lowered shares of Salarius Pharmaceuticals (NASDAQ:SLRX – Free Report) from a buy rating to a neutral rating in a report issued on Friday, FlyOnTheWall reports. Salarius Pharmaceuticals Stock Performance NASDAQ:SLRX opened at $0.65 on Friday. Salarius Pharmaceuticals has a 52 week low of $0.61 and a 52 week high of $7.20. The […] ....

Exchange Commission , Salarius Pharmaceuticals , News Ratings For Salarius Pharmaceuticals Daily , Hedge Funds Weigh In On Salarius Pharmaceuticals , Salarius Pharmaceuticals Stock Performance , Salarius Pharmaceuticals Inc , Renaissance Technologies , Free Report , Get Free Report , Salarius Pharmaceuticals Daily , Nasdaq Slrx , Ladenburg Thalm Sh ,